Anti-C1q antibody and antiphospholipid antibodies jointly predict thrombosis in membranous lupus nephritis: a retrospective cohort study
Journal of Thrombosis and Haemostasis · 2026-07 · 24 (7) · 2506-2513
DOI: 10.1016/j.jtha.2026.03.013 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-07. Verfasst von Jingjing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Complement C1q, Antibodies, Antiphospholipid, Lupus Nephritis, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Nanjing Jinling Hospital, National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND: Patients diagnosed with membranous lupus nephritis (MLN) exhibit a significantly elevated risk of thrombotic events. Although antiphospholipid antibodies (aPLs) are recognized as a risk factor, they do not fully explain the thrombotic burden, indicating the potential involvement of additional immune pathways. The contribution of anti-C1q antibodies, which are linked to lupus nephritis activity, to thrombosis is not well understood. OBJECTIVES: To evaluate the independent association between serum anti-C1q antibody levels and thrombotic events in patients with MLN, and to assess the combined effect of anti-C1q antibodies and aPL on thrombosis risk. METHODS: This retrospective cohort study involved an analysis of 424 patients with biopsy-confirmed pure MLN. The primary outcome measured was a composite of objectively confirmed arterial or venous thrombotic events. Multivariable Cox proportional hazards regression was used to evaluate the independent association between serum anti-C1q levels and thrombosis, adjusting for aPL status and other key clinical confounders. RESULTS: During a mean follow-up of 81.4 months, 48 (11.3%) patients experienced a thrombotic event. Each unit increase in anti-C1q level was associated with a 1.0% increase in thrombotic risk (adjusted hazards ratio, 1.010; 95% CI, 1.002-1.018). Patients in the highest anti-C1q tertile (≥13.83 U/mL) had a 2.71-fold higher risk (95% CI, 1.232-5.950) than those in the lowest. A significant dose-response relationship was observed. Strikingly, patients with both high anti-C1q levels and aPL positivity constituted the highest-risk phenotype, with a thrombosis incidence of 31.82% and an adjusted hazards ratio of 4.249 (95% CI, 2.016-8.955) compared with double-negative patients. CONCLUSION: In MLN, anti-C1q antibody levels are independent predictors of thrombosis and demonstrate a marked combined effect with aPL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
- National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. Electronic address: chengzhen33@hotmail.com.
- National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. Electronic address: htzhang163@163.com.
Förderung
- Nanjing Jinling Hospital
- National Key Research and Development Program of China
Zitieren
APA
Wang, J., Wang, X., Tu, Y., Chen, D., Zhao, L., Zhang, Y., Qiu, D., Cheng, Z., & Zhang, H. (2026). Anti-C1q antibody and antiphospholipid antibodies jointly predict thrombosis in membranous lupus nephritis: a retrospective cohort study. Journal of Thrombosis and Haemostasis, 24(7), 2506-2513. https://doi.org/10.1016/j.jtha.2026.03.013
Vancouver
Wang J, Wang X, Tu Y, Chen D, Zhao L, Zhang Y, et al. Anti-C1q antibody and antiphospholipid antibodies jointly predict thrombosis in membranous lupus nephritis: a retrospective cohort study. Journal of Thrombosis and Haemostasis. 2026;24(7):2506-2513. doi:10.1016/j.jtha.2026.03.013
BibTeX
@article{Wang2026,
author = {Wang, Jingjing and Wang, Xinyue and Tu, Yuanmao and Chen, Duqun and Zhao, Liang and Zhang, Yangyang and Qiu, Dandan and Cheng, Zhen and Zhang, Haitao},
title = {Anti-C1q antibody and antiphospholipid antibodies jointly predict thrombosis in membranous lupus nephritis: a retrospective cohort study},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {7},
pages = {2506--2513},
doi = {10.1016/j.jtha.2026.03.013}
}
EUVIMED